Diffuse, lake-like amyloid-β deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 7, 1998, Pages 674-683

  Wisniewski, Henryk M ^a   Sadowski, Marcin ^a,b,c   Jakubowska Sadowska, Katarzyna ^a,b   Tarnawski, Michal ^a   Wegiel, Jerzy ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c Foundation for Polish Science

Author keywords

Alzheimer disease; Amyloid ; Amyloid associated proteins; Fibrillization; Microgila; Neuron; Parvopyramidal layer of the presubiculum

Indexed keywords

AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0031811970     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199807000-00004     Document Type: Article

References (93)

1. Busciglio J, Lorenzo A, Yankner BA. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging 1992;13:609-12
2. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 1993;13:1676-87
3. Forloni G, Chiesa R, Smiroldo S, et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport 1993;4:523-36
4. Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 1994;91:12243-47
5. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of beta-amyloid peptides: Contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 1995;64:253-65
6. Cork LC, Masters C, Beyreuther K, Price DL. Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 1990;137:1383-92
7. Pappolla MA, Omar RA, Vinters HV. Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffused) senile plaques. Am J Pathol 1991;139:599-607
8. Probst A, Langui D, Ipsen S, Robakis N, Ulrich J. Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol 1991;83:21-29
9. Mann DMA, Jones D, South PW, Snowden JS, Neary D. Deposition of amyloid β protein in non-Alzheimer dementias. Evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease. Acta Neuropathol 1992;83:415-19
10. Selkoe DJ. Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 1994;53:438-47
11. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Fulllength amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 1996;149:1823-30
12. Wisniewskj HM, Wegiel J. Wang KC, Kujawa M, Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989;16:535-42
13. Wisniewski HM, Wegiel J, Popovitch ER. Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome. Dev Brain Dysfunct 1994;7:330-39
14. Wisniewski HM, Wegiel J, Kotula L. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 1996;22:3-11
15. Armstrong RA. Correlations between the morphology of diffuse and primitive β-amyloid (Aβ) deposits and the frequency of associated cells in Down's syndrome. Neuropathol Appl Neurobiol 1996;22:527-30
16. Halverson K, Fraser PE, Kirschner DA, Lansbury PT Jr. Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic beta-protein fragments. Biochemistry 1990;29:2639-44
17. Burdick D, Soreghan B, Kwon M, et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 1992;267:546-54
18. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32:4693-97
19. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 1994; 372:92-94
20. Lalowski M, Golabek A, Lemere CA, et al. The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid. J Biol Chem 1996;271: 33623-31
21. Gowing E, Roher AE, Woods AS, et al. Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 1994;269:10987-90
22. Higgins LS, Murphy GM Jr, Forno LS, Catalano R, Cordell B. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain. Am J Pathol 1996;149:585-96
23. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-66
24. Nishiyama E, Iwamoto N, Ohwada J, Arai H. Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: Investigation with the confocal laser scan microscope. Brain Res 1997;750:20-24
25. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102
26. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: Binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun 1993;192:359-65
27. Golabek AA, Soto C, Vogel T, Wisniewski T. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J Biol Chem 1996;271: 10602-606
28. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-35
29. Fraser PE, Nguyen JT, McLachlan DR, Abraham CR, Kirschner DA. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 1993;61:298-305
30. Eriksson S, Janciauskiene S, Lannfelt L. Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. Proc Natl Acad Sci USA 1995;92:2313-17
31. Fraser PE, Nguyen JT, Chin DT, Kirschner DA. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J Neurochem 1992;59:1531-40
32. Buee L, Ding W, Anderson JP, et al. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res 1993;627:199-204
33. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994; 144:337-47
34. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab Invest 1995;72:272-82
35. Gupta-Bansal R, Frederickson RC, Brunden KR. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 1995;270:18666-71
36. Wisniewski T, Golabek AA, Kida E, Wisniewski KE, Frangione B. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 1995;147:238-44
37. Harr SD, Uint L, Hollister R, Hyman BT. Mendez AJ. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 1996;66:2429-35
38. Zlokovic BV, Martel CL, Mackic JB, et al. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biophys Res Commun 1994;205:1431-37
39. Golabek A, Marques MA, Lalowski M, Wisniewski T Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid. Neurosci Lett 1995;191:79-82
40. Oda T, Wals P, Osterburg HH, et al. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol 1995;136:22-31
41. Kalus P, Braak H, Braak E, Bohl J. The presubicular region in Alzheimer's disease: Topography of amyloid deposits and neurofibrillary changes. Brain Res 1989;494:198-203
42. Akiyama H, Tago H, Itagaki S, McGeer PL. Occurrence of diffuse amyloid deposits in the presubicular parvopyramidal layer in Alzheimer's disease. Acta Neuropathol (Berl) 1990;79:537-44
43. Iseki E, Matsushita M, Kosaka K, Suzuki K, Amano N, Saito A. Morphological characteristics of senile plaques in familial Alzheimer's disease. Acta Neuropathol (Berl) 1990;80:227-32
44. Fukutani Y, Kobayashi K, Nakamura I, Watanabe K, Isaki K, Cairns NJ. Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci Lett 1995;200:57-60
45. Bobinski M, Wegiel J, Wisniewski HM, et al. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 1996;17:909-19
46. Davies DC, Horwood N, Isaacs SL, Mann DM. The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol (Berl) 1992;83:510-17
47. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-39
48. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653-59
49. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1: 213-16
50. Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I. A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 1991;12: 357-61
51. Braak H. Architectonics of the human telencephalic cortex. Berlin: Springer-Verlag, 1980
52. Amaral DG, Insausti R. Hippocampal formation. In: Paxinos G, ed. The human nervous system. San Diego: Academic Press, Inc., 1990:711-56
53. West MJ, Gundersen HJ. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990;296:1-22
54. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;16:4491-500
55. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59
56. Bobinski M, Wegiel J, Wisniewski HM, et al. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia 1995;6:205-10
57. Bartoo GT, Nochlin D, Chang D, Kim Y, Sumi SM. The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:531-40
58. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24
59. Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 1995; 345:956-58
60. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61
61. Shao Y, Gearing M, Mirra SS. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: A regional immunohistochemical study. J Neuropathol Exp Neurol 1997;56:376-81
62. Abraham CR, Kanemaru K, Mucke L. Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. Brain Res 1993;621:222-32
63. Ishiguro K, Shoji M, Yamaguchi H, et al. Differential expression of alpha 1-antichymotrypsin in the aged human brain. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:221-27
64. Ard MD, Bunge RP. Heparan sulfate proteoglycan and laminin immunoreactivity on cultured astrocytes: Relationship to differentiation and neurite growth. J Neurosci 1988;8:2844-58
65. Johnson-Green PC, Dow KE, Riopelle RJ. Characterization of glycosaminoglycans produced by primary astrocytes in vitro. Glia 1991;4:314-21
66. Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Bed) 1994;87:233-41
67. Wisniewski HM, Frackowiak J, Mazur-Kolecka B. In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 1995;183:120-23
68. Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol (Berl) 1992;84:117-27
69. Wegiel J, Wisniewski HM. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol (Bert) 1990;81:116-24
70. Perlmutter LS, Barron E, Chui HC. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 1990;119:32-36
71. Perlmutter LS, Scott SA, Barron E, Chui HC. MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J Neurosci Res 1992;33:549-58
72. Fine RE, Abraham CR. Hypothesis: β amyloid precursor protein is a key sorting and targeting receptor for neuropeptidases. Amyloid. Int J Exp Clin Invest 1997;4:233-38
73. Van Groen T, Wyss JM. The connections of presubiculum and parasubiculum in the rat. Brain Res 1990;518:227-43
74. Wyss JM, Van Groen T. Connections between the retrosplenial cortex and the hippocampal formation in the rat: A review. Hippocampus 1992;2:1-11
75. Shibata H. Direct projections from the anterior thalamic nuclei to the retrohippocampal region in the rat. J Comp Neurol 1993;337: 431-45
76. Insausti R, Amaral DG, Cowan WM. The entorhinal cortex of the monkey: II. Cortical afferents. J Comp Neurol 1987;264:356-95
77. Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989;290:213-42
78. White TD, Tan AM, Finch DM. Functional reciprocal connections of the rat entorhinal cortex and subicular complex with the medial frontal cortex: An in vivo intracellular study. Brain Res 1990;533: 95-106
79. Sadowski M, Morys J, Barcikowska M, Narkiewicz O. Astrocyte and microglia reaction in Alzheimer's disease in the hippocampal formation - a quantitative analysis. Alzheimer's Res 1995;1:71-76
80. Wisniewski T, Lalowski M, Bobik M, Russell M, Strosznajder J, Frangione B. Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. Biochem J 1996;313:575-80
81. Teller JK, Russo C, DeBusk LM, et al. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med 1996;2:93-95
82. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 1991;352:239-41
83. Higgins LS, Catalano R, Quon D, Cordell B. Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology. Ann N Y Acad Sci 1993;695:224-27
84. Higgins LS. Rodems JM, Catalano R, Quon D, Cordell B. Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for beta-APP751. Proc Natl Acad Sci USA 1995;92:4402-6
85. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995;373:523-27
86. Tagliavini E Giaccone G, Frangione B, Bugiani O. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett 1988;93:191-96
87. Yamaguchi H, Nakazato Y, Hirai S, Shoji M, Harigaya Y. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol 1989;135:593-97
88. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 1990;137:1293-97
89. Kamiguchi H, Yoshida K, Sagoh M, et al. Release of ciliary neurotrophic factor from cultured astrocytes and its modulation by cytokines. Neurochem Res 1995;20:1187-93
90. Patel AJ, Wickenden C, Jen A, de Silva HA. Glial cell derived neurotrophic factors and Alzheimer's disease. Neurodegeneration 1996;5:489-96
91. Wisniewski HM, Wegiel J. Spatial relationships between astrocytes and classical plaque components. Neurobiol Aging 1991;12:593-600
92. Yamaguchi H, Morimatsu M, Hirai S, Takahashi K. Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages. Acta Neuropathol (Berl) 1987;72:214-17
93. Kim KS, Wen GY, Bancher C, et al. Detection and quantification of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Commun 1990;7:113-22